The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,335,518 in first-year total cost, median $480,869.
Most frequent study sections
- Special Emphasis Panel[ZAI1 NKD-M (J1)]7
Most frequent institutions
- HDT BIO CORPORATION1
- ILIAD BIOTECHNOLOGIES, LLC1
- INTERNATIONAL AIDS VACCINE INITIATIVE1
- STATE UNIVERSITY OF NEW YORK AT BUFFALO1
- TEXAS BIOMEDICAL RESEARCH INSTITUTE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis1R61AI169026-01 | BEAMER, GILLIAN L | TEXAS BIOMEDICAL RESEARCH INSTITUTE, TX | $556,566 | ZAI1 |
| 2022 | RNA Vaccine Innovations for TB: Targeting the Mucosa1R61AI169207-01 | REED, STEVEN GREGORY | HDT BIO CORPORATION, WA | $550,719 | ZAI1 |
| 2022 | Novel Nanoparticle Respiratory Tract Mucosal Vaccine1R61AI169204-01 | QUINN, FREDERICK D | UNIVERSITY OF GEORGIA, GA | $484,996 | ZAI1 |
| 2022 | Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis1R61AI169199-01 | LOVELL, JONATHAN FOBREGON, ANDRES | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $480,869 | ZAI1 |
| 2022 | Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine1R61AI169071-01 | KHADER, SHABAANA A.MILLER, SHANNON MARILEE | WASHINGTON UNIVERSITY, MO | $467,889 | ZAI1 |
| 2022 | Development of Novel mRNA Vaccines Against Mycobacterium tuberculosis1R61AI169132-01 | KESTER, KENT E. | INTERNATIONAL AIDS VACCINE INITIATIVE, NY | $465,219 | ZAI1 |
| 2022 | Live nasal recombinant B. pertussis vaccine against tuberculosis1R61AI169201-01 | GOLDSTEIN, PETERLOCHT, CAMILLE | ILIAD BIOTECHNOLOGIES, LLC, NY | $329,260 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.